Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950170-25-018782
Filing Date
2025-02-12
Accepted
2025-02-12 15:36:42
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 13203
  Complete submission text file 0000950170-25-018782.txt   14840
Mailing Address 222 BERKELEY STREET, 13TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET, 13TH FLOOR BOSTON MA 02116 617-443-2040
MFN Partners Management, LP (Filed by) CIK: 0001732811 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: SCHEDULE 13G/A

Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Subject) CIK: 0001755237 (see all company filings)

EIN.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-90979 | Film No.: 25614523
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)